Ruxolitinib as a Salvage Therapy for Hemophagocytic Lymphohistiocytosis
Clinical trial NCT04120090 · UNKNOWN
Trial details
- NCT number
- NCT04120090
- Sponsor
- Beijing Friendship Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-01
- Primary completion
- 2020-07-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.